Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-25 · accession 0001193125-25-300821 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-26 | 2025-11-25 | CORT | Guyer William | Chief Development Off | S - Sale | $80.90 | -4,500 | 787 | -85% | -$364.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-25 | S | D | 4,500 | $80.90 | 787 | D | — | — | (F1) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.81 to $81.085 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |